Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-07

Clinical Trial Update: Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing colchicine for treating and preventing recurrent pericarditis after conventional treatment failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Azienda Sanitaria Locale 3, Torino | Conditions: Pericarditis, Recurrence | Phase 4 | Status: COMPLETED